BEXXAR - tositumomab I-131
Navigation: NDC > Supplier starting with: G > GLAXOSMITHKLINE LLCField | Value |
---|---|
NDC Code: | 0007-3261 |
Proprietary Name: | BEXXAR |
Suffix: | DOSIMETRIC |
Non-Proprietary Name: | tositumomab I-131 |
Dosage Form: | INJECTION |
Method: | INTRAVENOUS |
Original Marketing Date: | 15-07-2009 |
Category Name: | BLA |
Application Number: | BLA125011 |
Labeler: | GLAXOSMITHKLINE LLC |
Substance Name: | TOSITUMOMAB I-131 |
Active Numerator Strength: | .61 |
Active Ingredient Unit: | mCi/mL |
Pharm Classes: | CD20-directed Antibody Interactions [MoA],CD20-directed Radiotherapeutic Antibody [EPC],Radiopharmaceutical Activity [MoA] |
DEA Schedule: |